Top 5 drugs in the pipeline

September 22nd 2020

Some of the top medications were approved this summer, while others are awaiting FDA approval.

Major thyroid med recall underway

September 22nd 2020

Both recalls are due to sub-potency of drugs that treat hypothyroidism.

Jardiance to get new heart attack prevention indication

September 15th 2020

The top-selling diabetes drug will join semaglutide (Ozempic), which is approved to reduce the risk of major adverse cardiovascular events.

Carcinoma med snags Breakthrough Therapy Designation

September 14th 2020

The treatment is the first anti-PD-1 antibody from China to receive Breakthrough therapy designation.

Lung cancer's new drug based on precision medicine

September 8th 2020

Pharma makers expect the treatment to be available within a week.

FDA clears oral leukemia drug

September 08, 2020

The medication boasts a statistically significant improvement in overall survival versus placebo.

FDA expands emergency use authorization for remdesivir to include all hospitalized COVID-19 patients

August 31, 2020

One study questions the effectiveness of remdesivir past day 10 while others support its expanded use.

U.S. gov’t, Abbot team up to produce millions of rapid COVID-19 tests

August 28, 2020

The pharma maker will initially produce 150 million of the 5-minute tests.

FDA clears 2 therapies for rare conditions

August 18, 2020

Drug for a specific Duchenne muscular dystrophy mutation is only the second drug approved for the mutation.

Investigational lymphoma treatment gets FDA nod

August 17, 2020

The drug’s indication for marginal zone lymphoma (MZL) may not be approved until February 2021.